TG Therapeutics, Inc. (LON:0VGI)

TG Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,655	3,451	1,897	1,315	1,837	4,909
Market Cap Growth	52.29%	81.92%	44.26%	-28.44%	-62.57%	497.08%
Enterprise Value	3,657	3,381	1,803	1,237	1,595	4,754
Last Close Price	27.54	24.21	13.50	9.48	14.37	37.86
PE Ratio	82.84	184.75	190.66	-	-	-
PS Ratio	11.03	13.13	10.34	568.84	371.96	44096.70
PB Ratio	18.12	19.43	15.05	27.04	10.49	12.91
P/TBV Ratio	18.12	19.43	15.05	27.41	10.53	12.93
EV/Sales Ratio	10.72	12.87	9.83	535.24	322.82	42698.06
EV/EBITDA Ratio	55.29	100.79	110.20	-	-	-
EV/EBIT Ratio	56.68	100.95	111.33	-	-	-
Debt / Equity Ratio	0.92	1.14	0.69	1.42	0.34	0.08
Debt / EBITDA Ratio	2.89	5.74	4.82	-	-	-
Asset Turnover	0.82	0.73	0.89	0.01	0.01	0
Inventory Turnover	0.50	0.51	-	-	-	-
Quick Ratio	2.81	4.85	5.00	3.04	4.84	6.92
Current Ratio	3.86	6.25	5.92	3.16	5.06	6.99
Return on Equity (ROE)	26.63%	12.21%	11.57%	-151.36%	-92.03%	-100.14%
Return on Assets (ROA)	9.72%	5.78%	4.93%	-47.61%	-42.87%	-43.36%
Return on Capital (ROIC)	13.06%	7.00%	6.24%	-59.52%	-49.04%	-53.28%
Return on Capital Employed (ROCE)	16.20%	8.60%	7.50%	-	-	-
Earnings Yield	1.21%	0.54%	0.52%	-14.13%	-13.99%	-4.17%
FCF Yield	-1.18%	-0.94%	-1.30%	-11.12%	-11.90%	-3.21%
Buyback Yield / Dilution	-11.99%	-7.96%	-9.67%	-2.41%	-14.64%	-30.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.